Extended Release Medications
Extended Release Medications - Related Videos
07:07
Controlled-release of Chlorine Dioxide in a Perforated Packaging System to Extend the Storage Life and Improve the Safety of Grape Tomatoes
0 Views •
Cited by 14 •
2017
Here, we describe a protocol for the application of a novel, slow-release ClO2 product that reduces spoilage and extends the shelf life of fresh fruit. The slow-release ClO2 product was added to standard commercial grape tomato packaging and tested against Escherichia coli and Alternaria alternata.
06:59
A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
0 Views •
Cited by 5 •
2016
This study presents a novel device that offers an easy route to quickly provide medications and fluids in patients with limited or difficult IV access. This small-diameter device is placed in the distal third of the rectum, allowing for ongoing medication and fluids administration.
05:25
Extended 78% Hepatectomy in a Mouse Surgical Model
0 Views •
2024
The mouse model of partial 2/3 (66%) hepatectomy is well described in the literature, but more extended hepatectomies mimicking small-for-size syndrome after liver transplantation have seldom been used. We describe an extended 78% hepatectomy procedure in a mouse model that results in approximately 50% postoperative lethality in healthy mice.
01:27
Extended Versions of Green’s Theorem
0 Views •
2026
Green’s Theorem connects the circulation of a vector field around a closed curve with the behavior of the field across the region enclosed by that curve. It provides a way to replace a line integral around a boundary with a double integral over the interior region, making it especially useful in plane geometry, fluid flow, and vector calculus.Although Green’s Theorem is often introduced using simple regions without gaps, it can also be applied to regions made from several simple parts. This...
01:23
Inhaled Medications
0 Views •
2025
Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
FAQs
These formulation components regulate how quickly the active ingredient dissolves and becomes available for absorption. A matrix can control drug movement through the formulation, while a coating or other delivery system can alter the timing of release. The resulting release pattern influences how consistently therapeutic effects are maintained during the intended dosing interval.
Performance depends on the properties of the drug, the design of its formulation, and patient-specific factors. These variables can affect release, dissolution, absorption, and the consistency of drug concentrations over time. Consequently, the same general release approach may not produce identical clinical results for every drug or patient.
Extended release products are designed to reduce the concentration fluctuations associated with immediate-release products by making drug availability more gradual. They may also provide therapeutic effects with fewer doses. This difference can affect dosing convenience and the consistency of treatment, although the appropriate choice depends on the drug and the patient.
Formulation design determines how the active ingredient is released and becomes available for absorption, which directly affects therapeutic performance. Clinicians therefore consider the drug, the release mechanism, and patient-specific factors together rather than treating all extended release products as interchangeable. Appropriate selection can support consistent effects while contributing to safe treatment.
Administration requires attention to the specific formulation because its release behavior is central to treatment performance. Clinicians should account for the product’s design, the drug’s characteristics, and relevant patient-specific factors when planning therapy. Careful selection and administration help preserve the intended release pattern and support treatment effectiveness and safety.
Evaluation can focus on whether therapeutic effects remain consistent, whether drug concentration fluctuations are reduced, and whether the dosing schedule offers practical convenience. Clinicians can also consider safety in relation to the individual patient. These outcomes help determine whether the selected drug and formulation are providing the intended balance of effectiveness, consistency, and safe use.